⌘K

Enzon Pharmaceuticals, Inc. (ENZN)

$0.12 -10.37% $-0.01 Healthcare

Enzon Pharmaceuticals, Inc., together with its subsidiaries, engages in marketing drug products. The company's marketed drug product is PegIntron. It also has a marketing agreement relating to Vicineum drug. The company was founded in 1981 and is headquartered in Cranford, New Jersey.

Market cap

$8.98M

CEO

Mr. Andrew Rackear J.D.

Headquarters

Cranford, NJ

IPO Date

Feb 15, 1984

Price-to-earnings (PE) Ratio

12.10

Earnings-per-share (EPS)

$0.01

Cash ratio (TTM)

112.75

Current ratio (TTM)

113.75

Earnings yield (TTM)

15.29%

Net profit margin (TTM)

6,111.54%

PE ratio (TTM)

6.54

PEG ratio (TTM)

-0.27

Price-to-book ratio (TTM)

0.22

Price-to-sales ratio (TTM)

399.62

Quick ratio (TTM)

113.75

Return on assets (TTM)

3.38%

Return on equity (TTM)

4.50%

Similar stocks (7)

Eliem Therapeutics, Inc.

ELYM

$8.28 3.76% $0.30

Uptrend

PureTech Health plc

PRTC

$19.43 0.41% $0.08

Downtrend

Acrivon Therapeutics, Inc. Common Stock

ACRV

$7.59 0.40% $0.03

Neutral

PMV Pharmaceuticals, Inc.

PMVP

$1.52 0.66% $0.01

Downtrend

Tempest Therapeutics, Inc.

TPST

$1.41 0.00% $0.00

Downtrend

Kineta, Inc.

$0.57 -30.77% $-0.26

Downtrend

Cyclacel Pharmaceuticals, Inc.

CYCC

$1.02 -2.39% $-0.02

Downtrend

Neutral

Similar stocks (7)

Eliem Therapeutics, Inc.

ELYM

$8.28 3.76% $0.30

Uptrend

PureTech Health plc

PRTC

$19.43 0.41% $0.08

Downtrend

Acrivon Therapeutics, Inc. Common Stock

ACRV

$7.59 0.40% $0.03

Neutral

PMV Pharmaceuticals, Inc.

PMVP

$1.52 0.66% $0.01

Downtrend

Tempest Therapeutics, Inc.

TPST

$1.41 0.00% $0.00

Downtrend

Kineta, Inc.

$0.57 -30.77% $-0.26

Downtrend

Cyclacel Pharmaceuticals, Inc.

CYCC

$1.02 -2.39% $-0.02

Downtrend